|
US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
|
US4742049A
(en)
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
|
KR960000434B1
(ko)
*
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
IL99995A
(en)
|
1990-11-21 |
1997-11-20 |
Roussel Uclaf |
Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
|
|
US5985844A
(en)
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
|
FR2697524B1
(fr)
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2718450B1
(fr)
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
FR2739620B1
(fr)
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
FR2745290B1
(fr)
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
US5719272A
(en)
*
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
DE69733422T2
(de)
|
1996-09-04 |
2006-05-04 |
Abbott Laboratories, Abbott Park |
6-0-substituierte ketoliden mit antibakteriellen wirkung
|
|
EP0988308A1
(en)
|
1997-06-11 |
2000-03-29 |
Pfizer Products Inc. |
9-oxime erythromycin derivatives
|
|
US6407074B1
(en)
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
FR2777282B1
(fr)
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
|
US6020521A
(en)
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
FR2785612A1
(fr)
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
|
DE69933897T2
(de)
|
1998-12-10 |
2007-03-15 |
Pfizer Products Inc., Groton |
Carbamat- und Carbazatketolid-Antibiotika
|
|
CA2359708C
(en)
|
1999-01-27 |
2005-10-25 |
Pfizer Products Inc. |
Ketolide antibiotics
|
|
CA2411293A1
(en)
|
1999-01-28 |
2000-07-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
|
AR023264A1
(es)
*
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
|
JP2000351794A
(ja)
*
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
|
CA2370743A1
(en)
|
1999-04-16 |
2000-10-26 |
Dennis Hlasta |
Ketolide antibacterials
|
|
ATE340183T1
(de)
|
1999-04-16 |
2006-10-15 |
Kosan Biosciences Inc |
Antiinfektiöse makrolidderivate
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
|
WO2001010878A1
(fr)
|
1999-08-06 |
2001-02-15 |
Taisho Pharmaceutical Co., Ltd. |
Derives d'erythromycine a
|
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
|
JP2001261694A
(ja)
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
|
RU2230748C2
(ru)
*
|
2000-03-15 |
2004-06-20 |
Ханми Фарм. Ко., Лтд. |
Способ получения кларитромицина в виде кристаллов формы ii
|
|
NZ523693A
(en)
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
US20020115621A1
(en)
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
|
US20030143162A1
(en)
|
2001-05-18 |
2003-07-31 |
Speirs Robert John |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
CA2451391A1
(en)
*
|
2001-07-03 |
2003-01-16 |
Chiron Corporation |
C12 modified erythromycin macrolides and ketolides having antibacterial activity
|
|
US20030176327A1
(en)
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
|
BR0307898A
(pt)
|
2002-02-22 |
2004-12-07 |
Pharmacia Corp |
Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
|
|
JP4638225B2
(ja)
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
EP1553954A4
(en)
|
2002-06-17 |
2009-12-23 |
Epigenesis Pharmaceuticals Llc |
DIHYDRATE DEHYDROEPIANDROSTERONE AND METHOD FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE, COMPOSITIONS THEREOF
|
|
TW200420573A
(en)
|
2002-09-26 |
2004-10-16 |
Rib X Pharmaceuticals Inc |
Bifunctional heterocyclic compounds and methods of making and using same
|
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
|
EP1638549A4
(en)
|
2003-03-10 |
2011-06-15 |
Optimer Pharmaceuticals Inc |
NEW ANTIBACTERIAL AGENTS
|
|
US7163924B2
(en)
|
2003-04-25 |
2007-01-16 |
Chiron Corporation |
Ketolide derivatives
|
|
CA2523134A1
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Pyridyl substituted ketolide antibiotics
|
|
ES2278319T3
(es)
*
|
2003-05-13 |
2007-08-01 |
Glaxo Group Limited |
Nuevos compuestos con 14 y 15 miembros en el anillo.
|
|
US20050014706A1
(en)
|
2003-07-14 |
2005-01-20 |
Kanakeshwari Falzari |
Method of treating tuberculosis
|
|
US7457520B2
(en)
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
|
US20060116336A1
(en)
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
WO2005105821A2
(en)
|
2004-04-28 |
2005-11-10 |
Alembic Limited |
Process for the preparation of telithromycin
|
|
WO2005108412A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Ester linked macrolides useful for the treatment of microbial infections
|
|
US20080287376A1
(en)
|
2004-07-28 |
2008-11-20 |
Mohammad Salman |
Ketolide Derivatives as Antibacterial Agents
|
|
GB0424958D0
(en)
*
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0424959D0
(en)
*
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
CN2756842Y
(zh)
*
|
2004-11-12 |
2006-02-08 |
胡济荣 |
沙滩车用一体化发动机
|
|
JP2008526947A
(ja)
|
2005-01-14 |
2008-07-24 |
グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ |
抗マラリア活性を有する９ａ−カルバモイル−γ−アミノプロピル−および９ａ−チオカルバモイル−γ−アミノプロピル−アザリド
|
|
ATE429921T1
(de)
|
2005-01-14 |
2009-05-15 |
Glaxosmithkline Zagreb |
9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
|
|
JP2009500356A
(ja)
|
2005-07-07 |
2009-01-08 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クラリスロマイシン製剤
|
|
US20070167382A1
(en)
|
2005-11-15 |
2007-07-19 |
Nina Finkelstein |
Crystalline and amorphous forms of telithromycin
|
|
US20090075916A1
(en)
|
2005-11-23 |
2009-03-19 |
Upadhyay Dilip J |
Use of Macrolide Derivatives for Treating Acne
|
|
DOP2006000268A
(es)
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
|
JP2009539866A
(ja)
|
2006-06-05 |
2009-11-19 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換エリスロマイシンアナログの調製および有用性
|
|
CN101129383B
(zh)
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
|
US7742562B2
(en)
*
|
2007-06-27 |
2010-06-22 |
Accuray Incorporated |
Lower-torso assembly of a treatment couch useable in an X-ray environment
|
|
JP5855829B2
(ja)
*
|
2007-10-23 |
2016-02-09 |
インスメッド， インコーポレイテッド |
リポソーム化バンコマイシン製剤
|
|
EP2214484A4
(en)
*
|
2007-10-25 |
2013-01-02 |
Cempra Pharmaceuticals Inc |
PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
|
|
JP5711135B2
(ja)
*
|
2008-10-24 |
2015-04-30 |
センプラ ファーマシューティカルズ，インコーポレイテッド |
胃腸疾患を治療するための方法
|
|
WO2011008193A1
(en)
|
2009-07-13 |
2011-01-20 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
|
ES2608285T3
(es)
|
2009-09-10 |
2017-04-07 |
Cempra Pharmaceuticals, Inc. |
Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
|
|
ES2637072T3
(es)
|
2010-03-10 |
2017-10-10 |
Cempra Pharmaceuticals, Inc. |
Formulación parenteral de antibióticos macrólidos
|
|
MX361413B
(es)
|
2010-03-22 |
2018-12-05 |
Cempra Pharmaceuticals Inc Star |
Formas cristalinas de un macrólido y usos para las mismas.
|
|
CN102917708B
(zh)
|
2010-05-20 |
2015-11-25 |
森普拉制药公司 |
制备大环内酯和酮内酯及其中间体的方法
|
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
|
US20130164351A1
(en)
|
2010-08-30 |
2013-06-27 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
|
EP2613630A4
(en)
|
2010-09-10 |
2014-01-15 |
Cempra Pharmaceuticals Inc |
HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
|
|
JP6072778B2
(ja)
|
2011-05-23 |
2017-02-01 |
シーイーエム—１０２ ファーマシューティカルズ，インコーポレイテッド |
フシジン酸を含む組成物およびそのためのパッケージ
|
|
NZ700182A
(en)
|
2012-03-27 |
2017-02-24 |
Cempra Pharmaceuticals Inc |
Parenteral formulations for administering macrolide antibiotics
|
|
AU2014239959A1
(en)
|
2013-03-14 |
2015-10-01 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
|
CN105188712A
(zh)
|
2013-03-15 |
2015-12-23 |
森普拉制药公司 |
用于制备大环内酯抗菌剂的收敛方法
|